Read more: https://convention.bio.org/2019/
Follow us on LinkedIn or Twitter @ActoBioT for more updates.
Make an appointment for a chat via the partnerONE platform to discuss opportunities for the ActoBiotics® technology.
For more updates follow us on LinkedIn or Twitter @ActoBioT.
Read the article in full here: https://synbiobeta.com/actobio-therapeutics-cure-disease-with-living-medicines/
Chief Executive Officer Pieter Rottiers has been invited to participate in a panel discussion entitled “Evaluation of Combination Therapies to Address Unmet Clinical Needs” on Thursday 28th March at 16:30. For more information please visit www.as-immunetolerance.com